ParticipantsClare M. Tempany-Afdhal, MD, Charlestown, MA (Moderator) Research Grant, InSightec Ltd; Research Grant, Gilead Sciences, Inc; Advisory Board, Profound Medical Inc; Spouse, Employee, Spring Bank Pharmaceuticals, Inc; Spouse, Director, Trio Healthcare; Spouse, Consultant, Gilead Sciences, Inc; Spouse, Consultant, Merck & Co, Inc; Spouse, Consultant, Echosens SA; Spouse, Consultant, Shinogi; Spouse, Consultant, Ligand Pharmaceuticals, Inc; Spouse, Stock options, Spring Bank Pharmaceuticals, Inc; Spouse, Stock options, Allurion; Spouse, Stock options, Trio Healthcare; ;
1) To understand innovative approaches to improving MR efficiency. 2) To understand a novel framework for focused MR interpretations.
ParticipantsYoshimi Anzai, MD, Salt Lake City, UT (Presenter) Nothing to Disclose
yoshimi.anzai@hsc.utah.edu
ParticipantsJames G. Pipe, PhD, Rochester, MN (Presenter) Research Grant, Koninklijke Philips NV
pipe.james@mayo.edu
LEARNING OBJECTIVES1) List technologies appropriate for increasing MR Value. 2) Describe examples of high-value exams. 3) Debate the metrics involved in optimizing MR use.
ParticipantsMitchell D. Schnall, MD, PhD, Philadelphia, PA (Presenter) Research Grant, Siemens AG
ParticipantsClare M. Tempany-Afdhal, MD, Charlestown, MA (Presenter) Research Grant, InSightec Ltd; Research Grant, Gilead Sciences, Inc; Advisory Board, Profound Medical Inc; Spouse, Employee, Spring Bank Pharmaceuticals, Inc; Spouse, Director, Trio Healthcare; Spouse, Consultant, Gilead Sciences, Inc; Spouse, Consultant, Merck & Co, Inc; Spouse, Consultant, Echosens SA; Spouse, Consultant, Shinogi; Spouse, Consultant, Ligand Pharmaceuticals, Inc; Spouse, Stock options, Spring Bank Pharmaceuticals, Inc; Spouse, Stock options, Allurion; Spouse, Stock options, Trio Healthcare; ;